SUSAN PRICE: Open Payments
NPI 1962772616 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 8 payments from 6 companies in 2025. Trend: 2023 $23 · 2024 $150 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $101 |
| BioCryst US Sales Co., LLC | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Incyte Corporation | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $16 |
Products named: DUPIXENT, ORLADEYO, HYQVIA, OPZELURA, CAPLYTA, Ryaltris.
Industry payments across SC — which companies pay providers there.
